Pfizer Pulls Lyrica sNDA As Adjunct For Anxiety Disorder
This article was originally published in The Pink Sheet Daily
Executive Summary
The FDA gave the pregabalin sNDA for generalized anxiety disorder monotherapy a "complete response" in December for insufficient data.